Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia

NCT06599762 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes
Acute Myeloid Leukemia
Myelodysplastic/Myeloproliferative Neoplasm

Interventions

DRUG: Tranexamic acid
DRUG: Placebo

Sponsor

University of Manitoba